BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22727368)

  • 21. Treatment of recurrent primary spinal glioblastoma multiforme--case report.
    König SA; Roediger T; Spetzger U
    J Neurol Surg A Cent Eur Neurosurg; 2012 Aug; 73(4):256-61. PubMed ID: 21842458
    [No Abstract]   [Full Text] [Related]  

  • 22. Scalp, skull and brain metastasis of squamous cell carcinoma of the cervix--a rare entity.
    Vitorino-Araujo JL; Veiga JC; Barboza VR; de Souza N; Mayrink D; Nadais RF; Figueiredo EG
    Br J Neurosurg; 2013 Aug; 27(4):519-20. PubMed ID: 23410006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliosarcoma: a rare variant of glioblastoma multiforme.
    Rizvi S; Asghar AH; Mehboob J
    J Pak Med Assoc; 2010 Sep; 60(9):773-5. PubMed ID: 21381591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioblastoma with primitive neuroectodermal tumour-like components.
    Karina A; Jonker BP; Morey A; Selinger C; Gupta R; Buckland ME
    Pathology; 2012 Apr; 44(3):270-3. PubMed ID: 22437749
    [No Abstract]   [Full Text] [Related]  

  • 25. Fractal analysis of the susceptibility weighted imaging patterns in malignant brain tumors during antiangiogenic treatment: technical report on four cases serially imaged by 7 T magnetic resonance during a period of four weeks.
    Di Ieva A; Matula C; Grizzi F; Grabner G; Trattnig S; Tschabitscher M
    World Neurosurg; 2012; 77(5-6):785.e11-21. PubMed ID: 22120276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary gliosarcoma with extra-cranial metastases: a report and review of the literature.
    Dawar R; Fabiano AJ; Qiu J; Khushalani NI
    Clin Neurol Neurosurg; 2013 Apr; 115(4):375-80. PubMed ID: 22795300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Osteo-medullary metastases from cerebral glioblastoma].
    Pireyre C; Gaudin P; Falt-Rolachon I; Pasquier B; Juvin R; Phélip X
    Rev Rhum Ed Fr; 1993 Nov; 60(11):827-30. PubMed ID: 8054931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab and recurrent malignant gliomas: a European perspective.
    Wick W; Weller M; van den Bent M; Stupp R
    J Clin Oncol; 2010 Apr; 28(12):e188-9; author reply e190-2. PubMed ID: 20159801
    [No Abstract]   [Full Text] [Related]  

  • 29. Unusual bevacizumab-related complication of an oral infection.
    Magremanne M; Lahon M; De Ceulaer J; Reychler H
    J Oral Maxillofac Surg; 2013 Jan; 71(1):53-5. PubMed ID: 22705223
    [No Abstract]   [Full Text] [Related]  

  • 30. Glioblastoma multiforme presenting as a fungating mass extending through previous craniotomy site.
    Verma SK; Kumar A; Singh PK; Bindra A; Sagar S; Sharma BS
    Neurol India; 2013; 61(3):325-6. PubMed ID: 23860168
    [No Abstract]   [Full Text] [Related]  

  • 31. [Extracranial metastasis of glioblastoma multiforme].
    Santos AV; Saraiva PF; Santiago B
    Acta Med Port; 2003; 16(3):209-11. PubMed ID: 12868404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasis along the stereotactic biopsy trajectory in glioblastoma multiforme.
    Pierallini A; Caramia F; Piattella MC; Pantano P; Santoro A; Di Stefano D; Bozzao L
    Acta Neurochir (Wien); 1999; 141(9):1011-2. PubMed ID: 10526085
    [No Abstract]   [Full Text] [Related]  

  • 33. Scalp metastasis from glioblastoma.
    Allan RS
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):559. PubMed ID: 15026496
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemorrhagic papillary glioneuronal tumor mimicking cavernoma: two case reports.
    Benzagmout M; Karachi C; Mokhtari K; Capelle L
    Clin Neurol Neurosurg; 2013 Feb; 115(2):200-3. PubMed ID: 22717600
    [No Abstract]   [Full Text] [Related]  

  • 35. Minimally invasive awake craniotomy using Steiner-Lindquist stereotactic laser guidance.
    Bekar A; Bilgin H; Korfali G; Korfali E; Kocaeli H; Taskapiğlu O
    Minim Invasive Neurosurg; 2009 Aug; 52(4):176-9. PubMed ID: 19838971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.
    Chinot OL
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1413-27. PubMed ID: 23249106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Mrugala MM
    Neurology; 2009 Feb; 72(8):773; author reply 773-4. PubMed ID: 19248218
    [No Abstract]   [Full Text] [Related]  

  • 38. Glioblastoma multiforme with epithelial differentiation.
    Neelima R; Gopalakrishnan CV; Thomas B; Radhakrishnan VV
    Neurol India; 2011; 59(6):918-20. PubMed ID: 22234219
    [No Abstract]   [Full Text] [Related]  

  • 39. Spinal drop metastases in recurrent glioblastoma multiforme.
    Buhl R; Barth H; Hugo HH; Hutzelmann A; Mehdorn HM
    Acta Neurochir (Wien); 1998; 140(10):1001-5. PubMed ID: 9856242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?
    Rieger J; Bähr O; Ronellenfitsch MW; Steinbach J; Hattingen E
    J Clin Oncol; 2010 Sep; 28(27):e477; author reply e478. PubMed ID: 20585096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.